SAN FRANCISCO—To meet the increased colorectal cancer screening demands presented by the expansion of the eligible population to patients starting at 45 years of age, clinicians need to use all available modalities—including stool- and blood-based tests—and tailor screening approaches to maximize patient uptake.
About two-thirds of U.S. adults are being screened with current modalities. With the new recommendation to start screening at age 45, “we’ve unleashed a